Description
Description
This page contains brief details about the drug mesna, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Mesna is a cytoprotectant drug that belongs to the class of hemorrhagic cystitis inhibitors. FDA-approved mesna initially on 1998 for the treatment of hemorrhagic cystitis.
Mechanism of Action of Mesna
Mesna reduces ifosfamide (cancer medication) induced hemorrhagic cystitis by binding to certain metabolites, inhibiting their toxic effects on the bladder.
Uses of Mesna
Mesna is an intravenously administered drug. This medicine is used to reduce the risk of hemorrhagic cystitis (a condition that causes bladder inflammation and can result in serious bleeding) in people who receive ifosfamide (a medication used for treating cancer). It protects against some of the harmful effects of certain chemotherapy medications.
Mesna Dosage available
Mesna is available as an intravenous injection. The drug should be administered only by healthcare professionals experienced with cancer chemotherapy. Your physician will determine the dose and frequency of administration based on the type of cancer and severity of the disease. Do not self-administer the injection.
